INIS
cancer
20%
comparative evaluations
10%
data
20%
diarrhea
10%
diseases
10%
doses
20%
drugs
10%
fatigue
10%
hands
20%
hepatomas
100%
inclusions
10%
india
100%
liver
30%
patients
100%
range
10%
reduction
20%
side effects
20%
tolerance
100%
Nursing and Health Professions
Adverse Event
100%
Confidence Interval
14%
Diarrhea
14%
Disease
14%
Drug Dose Reduction
28%
Event Free Survival
28%
Hand Foot Syndrome
28%
Hospital
14%
Liver Cancer
14%
Liver Cell Carcinoma
100%
Liver Dysfunction
28%
Malignant Neoplasm
14%
Rash
28%
Side Effect
28%
Sorafenib
100%
Medicine and Dentistry
Adverse Event
100%
Diarrhea
14%
Drug Dose Reduction
28%
Event Free Survival
28%
Exanthem
28%
Hand Foot Syndrome
28%
Hepatocellular Carcinoma
100%
Liver Cancer
14%
Liver Dysfunction
28%
Malignant Neoplasm
14%
Progressive Disease
14%
Side Effect
28%
Sorafenib
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Diarrhea
14%
Disease
14%
Event Free Survival
28%
Hand Foot Syndrome
28%
Liver Cancer
14%
Liver Cell Carcinoma
100%
Liver Dysfunction
28%
Malignant Neoplasm
14%
Rash
28%
Side Effect
28%
Sorafenib
100%